Botulinum toxin type A therapy in cluster headache: A case report.
- Author:
So Young KWON
1
;
Dong Eon MOON
;
Young Hoon KIM
;
Sung Hyun LEE
;
Keon Hee RYU
Author Information
1. Department of Anesthesiology and Pain Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. demoon@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Botulinum toxin type A;
Cluster headache;
Occipi tal nerve block
- MeSH:
Botulinum Toxins;
Botulinum Toxins, Type A;
Central Nervous System;
Cluster Headache;
Headache;
Humans;
Male;
Middle Aged;
Migraine Disorders;
Nerve Block;
Sensation;
Suicide
- From:Anesthesia and Pain Medicine
2012;7(1):12-15
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cluster headache is a severe pain syndrome with a piercing, tearing sensation, nicknamed the suicide headache. It is associated with an autonomic symptom. No effective therapy is available in approximately 4-15% of patients with cluster headache. One of the treatment methods is occipital nerve block. It is conventionally performed with local anaesthetics, and in this case we used the botulinum toxin type A. Botulinum toxin is an effective therapeutic agent for various disorders, and has recently been discovered to be an effective treatment for chronic migraine. The efficacy of Botulinum toxin in headache invokes possible neurogenic effects that may reduce or even prevent sensitization of both the peripheral and central nervous system. Therefore, we describe a case of a 45-year-old male with a cluster headache that could not be controlled with conventional therapy. We performed botulium toxin type A therapy. Cluster headache VAS showed improvement after occipital nerve block using the botulinum toxin A.
